000157732 001__ 157732
000157732 005__ 20240328115556.0
000157732 0247_ $$2doi$$a10.3389/fneur.2021.654850
000157732 0247_ $$2pmid$$apmid:34054698
000157732 0247_ $$2pmc$$apmc:PMC8160300
000157732 0247_ $$2altmetric$$aaltmetric:105841238
000157732 037__ $$aDZNE-2021-01189
000157732 041__ $$aEnglish
000157732 082__ $$a610
000157732 1001_ $$0P:(DE-2719)2812560$$aPietrowski, Marie J$$b0$$eFirst author
000157732 245__ $$aGlial Purinergic Signaling in Neurodegeneration.
000157732 260__ $$aLausanne$$bFrontiers Research Foundation$$c2021
000157732 3367_ $$2DRIVER$$aarticle
000157732 3367_ $$2DataCite$$aOutput Types/Journal article
000157732 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1711546509_24240$$xReview Article
000157732 3367_ $$2BibTeX$$aARTICLE
000157732 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157732 3367_ $$00$$2EndNote$$aJournal Article
000157732 520__ $$aPurinergic signaling regulates neuronal and glial cell functions in the healthy CNS. In neurodegenerative diseases, purinergic signaling becomes dysregulated and can affect disease-associated phenotypes of glial cells. In this review, we discuss how cell-specific expression patterns of purinergic signaling components change in neurodegeneration and how dysregulated glial purinergic signaling and crosstalk may contribute to disease pathophysiology, thus bearing promising potential for the development of new therapeutical options for neurodegenerative diseases.
000157732 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000157732 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000157732 650_7 $$2Other$$aATP
000157732 650_7 $$2Other$$aAlzheimer
000157732 650_7 $$2Other$$aadenosine
000157732 650_7 $$2Other$$aastrocyte
000157732 650_7 $$2Other$$amicroglia
000157732 650_7 $$2Other$$aneurodegeneration
000157732 650_7 $$2Other$$aoligodendrocyte
000157732 650_7 $$2Other$$apurine
000157732 7001_ $$0P:(DE-2719)9001956$$aGabr, Amrq$$b1$$udzne
000157732 7001_ $$0P:(DE-2719)2812648$$aKozlov, Stanislav$$b2
000157732 7001_ $$aBlum, David$$b3
000157732 7001_ $$0P:(DE-2719)2812038$$aHalle, Annett$$b4
000157732 7001_ $$aCarvalho, Kevin$$b5
000157732 773__ $$0PERI:(DE-600)2564214-5$$a10.3389/fneur.2021.654850$$gVol. 12, p. 654850$$p654850$$tFrontiers in neurology$$v12$$x1664-2295$$y2021
000157732 8564_ $$uhttps://pub.dzne.de/record/157732/files/DZNE-2021-01189.pdf$$yOpenAccess
000157732 8564_ $$uhttps://pub.dzne.de/record/157732/files/DZNE-2021-01189.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000157732 909CO $$ooai:pub.dzne.de:157732$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000157732 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812560$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000157732 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001956$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000157732 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812648$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000157732 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812038$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000157732 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000157732 9141_ $$y2021
000157732 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000157732 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-28
000157732 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000157732 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROL : 2021$$d2022-11-18
000157732 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T13:11:28Z
000157732 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000157732 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T13:11:28Z
000157732 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000157732 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000157732 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000157732 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000157732 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-11T13:11:28Z
000157732 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-28
000157732 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000157732 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-28
000157732 9201_ $$0I:(DE-2719)1013034$$kAG Halle$$lMicroglia and Neuroinflammation$$x0
000157732 980__ $$ajournal
000157732 980__ $$aVDB
000157732 980__ $$aUNRESTRICTED
000157732 980__ $$aI:(DE-2719)1013034
000157732 9801_ $$aFullTexts